Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07442058 · ClinicalTrials.gov registry record · NA
Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD
A NA study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT07442058: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT07442058 is a NA study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07442058, a NA study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
Impaired inhibitory response manifests clinically as increased impulsivity, which leads to poorer affective, cognitive, social, and occupational functioning. Neuropsychiatric disorders prevalent among Veterans, such as Attention Deficit/Hyperactivity Disorder (ADHD), are associated with poor inhibitory control. The mainstay of clinical treatment for ADHD is psychostimulants, yet these medications have significant risks, including dependence and numerous side effects. Thus, novel and non-pharmacological therapeutic strategies are needed. Intermittent Theta Burst Stimulation, a newer form of transcranial magnetic stimulation, has emerged as a promising tool for modulating inhibitory neuronal circuits. This research proposal will investigate the feasibility and acceptability of iTBS on inhibitory control and impulsivity through a randomized controlled trial to inform clinical observations. The long-term goal is to improve impulsivity, social and occupational functioning, and enhance the quality of life for Veterans.
Interventions
- DEVICE Sham Stimulation
- DEVICE Intermittent Theta-Burst Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07442058
The ClinicalTrials.gov registry entry for NCT07442058 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Stimulation is the first listed.
NCT07442058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07442058 about?
NCT07442058 is a clinical study titled "Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD". Impaired inhibitory response manifests clinically as increased impulsivity, which leads to poorer affective, cognitive, social, and occupational functioning. Neuropsychiatric disorders prevalent among Veterans, such as Attention Deficit/Hyperactivity Disorder (ADHD), are associated with poor inhibit...
What is the current status of trial NCT07442058?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2026-07-01. Estimated completion is 2028-07-01.
What interventions are being tested in trial NCT07442058?
The interventions under investigation include: Sham Stimulation (DEVICE), Intermittent Theta-Burst Stimulation (DEVICE).
Who is sponsoring clinical trial NCT07442058?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.